Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapyC V Fletcher, R C Brundage, R P Remmel, et al.AIDS (London, England)|November 4, 2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected personsC V Fletcher, S P Kawle, T N Kakuda, et al.The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.Antimicrobial Agents and Chemotherapy|March 1, 1994
Foscarnet for suppression of human immunodeficiency virus replicationC V Fletcher, A C Collier, F S Rhame, et al.AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.Pediatrics|June 1, 1996
Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic and virologic effectsM W Kline, C V Fletcher, M E Federici, et al.Clinical Pharmacology and Therapeutics|June 29, 2007
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patientsJ J Kiser, M L Carten, C L Aquilante, et al.The Journal of Pediatrics|April 17, 1998
A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virusM W Kline, C V Fletcher, A T Harris, et al.Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.Pageof 8